Search For

ROS1 mutations promote an immunosuppressive tumor microenvironment via MYC to confer immune evasion in head and neck cancer

Lactylation: a novel driver of drug resistance in the tumor microenvironment

Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLC

Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation

The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistance

Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma

Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance

Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers

Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma